Publications
Har-Noy M, Or R.J Transl Med. 2020 May 12;18(1):196. doi: 10.1186/s12967-020-02363-3.PMID: 32398026
Har-Noy M, Slavin S.Med Hypotheses. 2008;70(6):1186-92. doi: 10.1016/j.mehy.2007.10.008. Epub 2007 Dec 3.PMID: 18054441
Har-Noy M, Zeira M, Weiss L, Fingerut E, Or R, Slavin S.Leuk Res. 2009 Apr;33(4):525-38. doi: 10.1016/j.leukres.2008.08.017. Epub 2008 Oct 1.PMID: 18834631
Har-Noy M, Zeira M, Weiss L, Slavin S.Leuk Res. 2008 Dec;32(12):1903-13. doi: 10.1016/j.leukres.2008.05.007. Epub 2008 Jun 18.PMID: 18565579
Th-1 lymphocytes induce dendritic cell tumor killing activity by an IFN-γ-dependent mechanism.
LaCasse CJ, Janikashvili N, Larmonier CB, Alizadeh D, Hanke N, Kartchner J, Situ E, Centuori S, Har-Noy M, Bonnotte B, Katsanis E, Larmonier N.J Immunol. 2011 Dec 15;187(12):6310-7. doi: 10.4049/jimmunol.1101812. Epub 2011 Nov 9.
Janikashvili N, LaCasse CJ, Larmonier C, Trad M, Herrell A, Bustamante S, Bonnotte B, Har-Noy M, Larmonier N, Katsanis E.Blood. 2011 Feb 3;117(5):1555-64. doi: 10.1182/blood-2010-06-288621. Epub 2010 Dec 1.PMID: 21123824
Mayer-Sonnenfeld T, Har-Noy M, Lillehei KO, Graner MW.Int J Hyperthermia. 2013 Sep;29(6):520-7. doi: 10.3109/02656736.2013.796529. Epub 2013 Jun 4.PMID: 23734882
Epple LM, Bemis LT, Cavanaugh RP, Skope A, Mayer-Sonnenfeld T, Frank C, Olver CS, Lencioni AM, Dusto NL, Tal A, Har-Noy M, Lillehei KO, Katsanis E, Graner MW.Int J Hyperthermia. 2013 Aug;29(5):390-8. doi: 10.3109/02656736.2013.800997. Epub 2013 Jun 20.PMID: 23786302
Abstracts
Response of HER2+ breast cancer patients to allogeneic cell immunotherapy.
DOI: 10.1200/jco.2012.30.15_suppl.e13013 Journal of Clinical Oncology 30, no. 15_suppl
Individualized cancer vaccine to elicit tumor debulking immunity in advanced HCC.
DOI: 10.1200/JCO.2018.36.15_suppl.e15054 Journal of Clinical Oncology 36, no. 15_suppl
Effect of therapeutic vaccine on CTLA4 and tumor debulking response in recurrent and metastatic HNSCC
J Clin Oncol 36, 2018 (suppl 5S; abstr 115).
DOI: 10.1200/JCO.2018.36.5_suppl.115
Phase I/IIb trial: In-situ vaccine for metastatic colorectal cancer.
J Clin Oncol 36, 2018 (suppl 4S; abstr TPS871)
DOI: 10.1200/JCO.2018.36.4_suppl.TPS87
Personalized vaccine for advanced HCC
J Clin Oncol 36, 2018 (suppl 4S; abstr TPS527)
DOI:
10.1200/JCO.2018.36.4_suppl.TPS527 poster
Press Anouncements
FDA Clears Universal Viral Vaccine trial
Publication of technical rational for universal viral vaccine for elderly
A ‘Pan-Viral’ Vaccine Designed to Protect the Elderly from Known, and Unknown, Viruses
Next generation cancer vaccine from sister company Immunovative therapies
Could an immunotherapy treatment from Israel cure cancer?
Mirror Effect Technology
Patent strategy